August 21, 2008 Sweden
Biotech Scandinavia writes about Diamyd.Biotech Scandinavia writes about Diamyd and the GAD Phase II trials conducted by Neurologix.
Read the article
here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.